Efficacy of the unified protocol for the treatment of emotional disorders in the Spanish public mental health system using a group format: study protocol for a multicenter, randomized, non-inferiority controlled trial

Jorge Osma, Carlos Suso-Ribera, Azucena García-Palacios, Elena Crespo-Delgado, Cristina Robert-Flor, Ana Sánchez-Guerrero, Vanesa Ferreres-Galan, Luisa Pérez-Ayerra, Amparo Malea-Fernández, Mª Ángeles Torres-Alfosea, Jorge Osma, Carlos Suso-Ribera, Azucena García-Palacios, Elena Crespo-Delgado, Cristina Robert-Flor, Ana Sánchez-Guerrero, Vanesa Ferreres-Galan, Luisa Pérez-Ayerra, Amparo Malea-Fernández, Mª Ángeles Torres-Alfosea

Abstract

Background: Emotional disorders, which include both anxiety and depressive disorders, are the most prevalent psychological disorders according to recent epidemiological studies. Consequently, public costs associated with their treatment have become a matter of concern for public health systems, which face long waiting lists. Because of their high prevalence in the population, finding an effective treatment for emotional disorders has become a key goal of today's clinical psychology. The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders might serve the aforementioned purpose, as it can be applied to a variety of disorders simultaneously and it can be easily performed in a group format.

Methods: The study is a multicenter, randomized, non-inferiority controlled clinical trial. Participants will be 220 individuals with emotional disorders, who are randomized to either a treatment as usual (individual cognitive behavioral therapy) or to a Unified Protocol condition in group format. Depression, anxiety, and diagnostic criteria are the primary outcome measures. Secondary measures include the assessment of positive and negative affect, anxiety control, personality traits, overall adjustment, and quality of life. An analysis of treatment satisfaction is also conducted. Assessment points include baseline, post-treatment, and three follow-ups at 3, 6, and 12 months. To control for missing data and possible biases, intention-to-treat and per-protocol analyses will be performed.

Discussion: This is the first randomized, controlled clinical trial to test the effectiveness of a transdiagnostic intervention in a group format for the treatment of emotional disorders in public settings in Spain. Results obtained from this study may have important clinical, social, and economic implications for public mental health settings in Spain.

Trial registration: Retrospectively registered at https://ichgcp.net/clinical-trials-registry/NCT03064477" title="See in ClinicalTrials.gov">NCT03064477 (March 10, 2017). The trial is active and recruitment is ongoing. Recruitment is expected to finish by January 2020.

Keywords: Controlled trial; Emotional disorders; Group therapy; Multicenter; Public mental health; Randomized; Transdiagnostic; Unified protocol.

Conflict of interest statement

Authors’ information

J.O. is an Associate professor and Director of the General Health Psychology Master at the Psychology and Sociology Department of the University of Zaragoza. He is the PI of this project and an effective member of the “Psychological research and technological tools” (INPAT) research group (S-116 Aragon Government) and the Instituto de Investigación Sanitaria de Aragón. C.S.R. is a Postdoctoral researcher at the Department of Basic and Clinical Psychology and Psychobiology of the Universitat Jaume I. A.G.P. is Full professor of Psychopathology at the Department of Basic and Clinical Psychology and Psychobiology of the Universitat Jaume I. E.C.D. is an Assistant professor at the Department of Basic and Clinical Psychology and Psychobiology of the Universitat Jaume I. C.R.F. and A.S.G. are Clinical Psychologists at the La Fuente de San Luís Mental Health Unit in Valencia. V.F.G. is a Clinical Psychologist at the Hospital Comarcal de Vinaròs in Castellón. L.P.A. is a Clinical Pshychologist at the Centro de Salud Mental La Milagrosa in Pamplona. A.M.F. is a Clinical Pshychologist at the La Malvarrosa Mental Health Center in Valencia. M.A.T.A. is a Clinical Pshychologist at the Hospital General Universitario de Alicante.

Ethics approval and consent to participate

The study have been performed in accordance with the Declaration of Helsinki and have been approved and registered by the ethical and research committees from the following collaborating centers: Hospital General Clínico de Elda (PUG-02-14), Hospital Clínico Universitario de Valencia (F-CE-GEva-15), Hospital Universitario Dr. Peset (CEIC 53/15), CSM IIA Milagrosa (Pyto2016/41), and Hospital Comarcal de Vinaròs (0103–2016).In addition, the protocol study have been registered retrospectively at Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Study flow chart
Fig. 2
Fig. 2
Study schedule of enrolment, interventions, and assessments

References

    1. Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess. 2009;21:256–271. doi: 10.1037/a0016608.
    1. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van OJ, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–679. doi: 10.1016/j.euroneuro.2011.07.018.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (5th ed.) Washington: Author; 2013.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.) Washington: Author; 2000.
    1. Roca M, Gili M, Garcia-Garcia M, Salva J, Vives M, Garcia Campayo J, et al. Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord. 2009;119:52–58. doi: 10.1016/j.jad.2009.03.014.
    1. Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3:415–424. doi: 10.1016/S2215-0366(16)30024-4.
    1. Parés-Badell O, Barbaglia G, Jerinic P, Gustavsson A, Salvador-Carulla L, et al. Cost of disorders of the brain in Spain. PLoS One. 2014; 10.1371/journal.pone.0105471.
    1. Barlow DH, Ellard KK, Fairholme CP, Farchione TJ, Boisseau CL, Allen LB, Ehrenreich-May J. The unified protocol for transdiagnostic treatment of emotional disorders: client workbook. New York, NY: Oxford University Press; 2011.
    1. Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, Ehrenreich-May J. The unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. New York: Oxford University Press; 2011.
    1. Suárez L, Bennett S, Goldstein C, Barlow DH. In: Understanding anxiety disorders from a “triple vulnerabilities” framework. Antony MM, Stein MB, editors. New York: Oxford Handbooks; 2009. pp. 153–172.
    1. Gross JJ, Thompson RA. Emotion regulation: conceptual foundations. In: Gross JJ, editor. Handbook of emotion regulation. New York: Guilford Press; 2007. pp. 3–24.
    1. Bullis JR, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Carl JR, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders: preliminary exploration of effectiveness for group delivery. Behav Modif. 2015;39:295–321. doi: 10.1177/0145445514553094.
    1. Osma J, Castellano C, Crespo E, García-Palacios A. The unified protocol for Transdiagnostic treatment of emotional disorders in format group in a Spanish public mental health setting. Behavioral psychology. Psicol Conduct. 2015;23(3):447–466.
    1. Reinholt N, Aharoni R, Winding C, Rosenberg N, Rosenbaum B, Arnfred S. Transdiagnostic group CBT for anxiety disorders: the unified protocol in mental health services. Cogn Behav Ther. 2017;46:29–43. doi: 10.1080/16506073.2016.1227360.
    1. Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the unified protocol for Transdiagnostic treatment of emotional disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42:210–30. doi: 10.1177/0145445517724539.
    1. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDER), Center for Biologics Evaluation and Research (CBER) (2016). Non-Inferiority Clinical Trials to Establish Effectiveness Guidance for Industry. Retrieved from . Accessed 5 Feb 2018.
    1. Beltman MW, Oude Voshaar RC, Speckens AE. Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials. Br J Psychiatry. 2010;197(1):11–19. doi: 10.1192/bjp.bp.109.064675.
    1. Gil PJ, Carrillo FX, Meca J. Effectiveness of cognitive-behavioural in social phobia: a meta-analytic review. Psychol Spain. 2001;5(1):17–25.
    1. van Straten A, Geraedts A, Verdonck-de Leeuw I, Andersson G, Cuijpers P. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res. 2010;69(1):23–32. doi: 10.1016/j.jpsychores.2010.01.019.
    1. Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010;5:e13196. doi: 10.1371/journal.pone.0013196.
    1. Julious SA. Sample sizes for clinical trials with normal data. Statist Med. 2004;23:1921–1986. doi: 10.1002/sim.1783.
    1. Sealed Envelope Ltd. 2012. Power calculator for continuous outcome non-inferiority trial. Retrieved from . Accessed 2 Feb 2018.
    1. Beck AT, Steer RA, Brown GK. Manual for the Beck depression inventory II. San Antonio: Psychological Corporation; 1996.
    1. Sanz J, Perdigón AL, Vázquez C. The Spanish adaptation of the Beck's depression inventory-II (BDI-II): 2. Psychometric properties in the general population. Clínica y Salud. 2003;14:249–280.
    1. Beck AT, Steer R. Beck anxiety inventory manual. San Antonio: Psychological Corporation; 1993.
    1. Magán I, Sanz J, García-Vera MP. Psychometric properties of a Spanish version of the Beck anxiety inventory (BAI) in general population. Span J Psychol. 2008;11:626–640.
    1. Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, Gallagher MW, Barlow DH. The unified protocol for the Transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012;(3):666–78.
    1. Ministerio de Justicia. Boletin Oficial del Estado, n°17 [BOE-A-2008-979].
    1. Brown TA, Di Nardo PA, Barlow DH. Anxiety disorder interview schedule for DSM-IV (ADIS-IV). Adult and lifetime version. Clinical manual. San Antonio: Psychological Corporation; 1994.
    1. Bentley KH, Gallagher MW, Carl JR, Barlow HD. Development and validation of the overall depression severity and impairment scale. Psychol Assessment. 2014;26:815–830. doi: 10.1037/a0036216.
    1. Norman SB, Cissell S, Means-Christensen AJ, Stein MB. Development and validation of an overall anxiety severity and impairment scale (OASIS) Depress Anxiety. 2006;23:245–249. doi: 10.1002/da.20182.
    1. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063–1070. doi: 10.1037/0022-3514.54.6.1063.
    1. Sandín B, Chorot P, Lostao L, Joiner TE, Santed MA, Valiente RM. PANAS Positive and Negative affect schedule: factorial validation and transcultural convergence. Psicothema. 1999;11:37–51.
    1. Rapee RM, Craske MG, Brown TA, Barlow DH. Measurement of perceived control over anxiety-related events. Behav Ther. 1996;27:279–293. doi: 10.1016/S0005-7894(96)80018-9.
    1. Osma J, Barrada JR, García-Palacios A, Navarro-Haro M, Aguilar A. Internal structure and clinical utility of the anxiety control questionnaire-revised (ACQ-R) Spanish version. Span J Psychol. 2016;19:1–9.
    1. Costa PT, McCrae RR. Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) Madrid: TEA; 1999.
    1. Mezzich JE, Ruipérez MA, Pérez C, Yoon G, Liu J, Mahmud S. The Spanish version of the quality of life index: presentation and validation. J Nerv Ment Dis. 2000;188:301–305. doi: 10.1097/00005053-200005000-00008.
    1. Echeburúa E, Corral P, Fernández-Montalvo J. Maladjustment inventory (MI): psychometric properties in clinical contexts. Análisis y Modificación de Conducta. 2000;26:325–340.
    1. Davey D, Thompson JA. Assessing sensitivity to assumptions in mixed effects analyses of stepped-wedge trials. Trials. 2015;16(Suppl 2):O46. doi: 10.1186/1745-6215-16-S2-O46.
    1. Baldwin SA, Murray DM, Shadish WR. Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments. J Consult Clin Psychol. 2005;73(5):924–935. doi: 10.1037/0022-006X.73.5.924.
    1. Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CM, Mulder RT, Joyce PR. Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007;190:496–502. doi: 10.1192/bjp.bp.106.024729.
    1. Koch GG. Comments on ‘current issues in non-inferiority trials’ by Thomas R. Fleming. Stat Med. 2008;27:333–342. doi: 10.1002/sim.2923.
    1. Piaggio G, Elbourne D, Pocock S, Evans S, Altman D. Reporting of noninferiority and equivalence randomized trials: extension of the consort 2010 statement. JAMA. 2012;308:2594–2604. doi: 10.1001/jama.2012.87802.
    1. Schneider KM, O’Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Out. 2009;7:82. doi: 10.1186/1477-7525-7-82.
    1. Yalom ID, Leszcz M. The theory and practice of group therapy. 5. New York: IUP; 2005.
    1. Renjilian DA, Perri MG, Nezu AM, McKelvey WF, Shermer RL, Anton SD. Individual versus group therapy for obesity: effects of matching participants to their treatment preferences. J Consult Clin Psychol. 2001;69(4):717–721. doi: 10.1037/0022-006X.69.4.717.

Source: PubMed

3
Iratkozz fel